Effect of statins on endothelial function in patients with acute coronary syndrome: a prospective study using adhesion molecules and flow-mediated dilatation
| Autor: | Berrin Umman, Ahmet Kaya Bilge, Selda Can Arkaya, Ümit Türkoğlu, İlknur Altun, Ibrahim Altun, Fahrettin Oz |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Acute coronary syndrome
medicine.medical_specialty Cell adhesion molecule business.industry Statins Inflammation General Medicine medicine.disease Flow-mediated dilatation Gastroenterology Internal medicine medicine.artery Immunology medicine Original Article Endothelial dysfunction Brachial artery medicine.symptom Endothelin receptor Prospective cohort study business Adhesion molecules Lipoprotein Ultrasonography |
| Zdroj: | Journal of Clinical Medicine Research |
| ISSN: | 1918-3003 |
| Popis: | Background: Accumulating evidence suggests that inflammatory mechanisms play a central role in the development, progression and outcome of atherosclerosis. Recent evidence suggests that statins improve anti-inflammatory, anti-thrombotic and endothelial functions, along with their lipid-decreasing effects. We examined the effect of statins on endothelial function using biochemical markers of endothelial dysfunction and brachial artery flow-mediated dilatation (FMD). Methods: Thirty male patients presenting with acute coronary syndrome (ACS) and 26 age-matched healthy control subjects aged 40 - 60 years who were not on any medication were enrolled in the study. The patient group was started on atorvastatin (40 mg/day) without consideration of their low-density lipoprotein (LDL)-cholesterol levels. Endothelin, sICAM and E-selectin from stored serum samples were measured using commercially available enzyme-linked immunosorbant assays (ELISAs). Endothelial function was assessed using brachial artery FMD. Results: Prior to statin treatment, E-selectin, sICAM and endothelin levels, endothelial dysfunction markers, were 99.74 ± 34.67 ng/mL, 568.8 ± 149.0 ng/mL and 0.62 ± 0.33 fmol/mL, respectively in the patient group. E-selectin and sICAM levels were significantly higher in the patients than in the control subjects (P < 0.001); however, endothelin levels were not significantly different between groups. Statin treatment significantly reduced E-selectin and sICAM levels (P < 0.001); however, the decrease in endothelin levels was not statistically significant. %FMD values were significantly increased after statin treatment (P = 0.005), and levels of C-reactive protein (CRP), an inflammation marker, were significantly reduced. Conclusion: Our results indicate that statins play an important role in treatment endothelial dysfunction by reducing adhesion of inflammatory cells. J Clin Med Res. 2014;6(5):354-361 doi: http://dx.doi.org/10.14740/jocmr1863w |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|